Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 36
Filtrar
1.
Cent Eur J Public Health ; 30(Supplement): S57-S62, 2022 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-35841227

RESUMO

OBJECTIVES: This work aimed to determine the representation and resistance of bacteria belonging to the genus Staphylococcus and Enterococcus on inanimate surfaces of two selected workplaces of the University Hospital of L. Pasteur in Kosice (UHLP) and to investigate their importance in the hospital environment. The men's ward of the Department of Internal Medicine (DIM) and the Department of Anaesthesiology and Intensive Care (DAIC) were chosen. METHODS: Using sterile sampling kits, a total of 182 swabs were collected from the inanimate surfaces of both UHLP workplaces. The swabs were then transported to a microbiological laboratory and inoculated onto sterile culture media (blood agar containing 5% ram erythrocytes). After culturing (24-48 hours, in a thermostat at constant temperature 37 °C), bacterial colonies were identified by mass spectrometry on a MALDI TOF MS. Bacteria belonging to the genera Staphylococcus and Enterococcus were subsequently separated from the spectrum of identified bacteria. Nosocomial significant strains of staphylococci (Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus aureus) and all isolated enterococci were subjected to susceptibility testing for selected antibiotics using the disk diffusion method - E-tests. RESULTS: Several members of the genus Staphylococcus were identified from the inanimate surfaces of both workplaces. These were mainly coagulase-negative strains - Staphylococcus epidermidis (45), Staphylococcus capitis (34), Staphylococcus haemolyticus (20), Staphylococcus hominis (45), Staphylococcus pasteuri (2), Staphylococcus sroph (1), Staphylococcus simulans (3), and Staphylococcus warneri (4). Staphylococcus aureus strains were also identified (2). Nosocomial significant isolates were tested for susceptibility to the antibiotics cefoxitin (FOX) and oxacillin (OXA). Two members of the genus Enterococcus - Enterococcus faecium (7) and Enterococcus faecalis (8) were isolated. All strains were subject to vancomycin susceptibility testing using the disk method.


Assuntos
Infecção Hospitalar , Infecções Estafilocócicas , Animais , Antibacterianos/uso terapêutico , Bactérias , Enterococcus , Hospitais , Humanos , Masculino , Testes de Sensibilidade Microbiana , Ovinos , Infecções Estafilocócicas/microbiologia , Staphylococcus
2.
Prague Med Rep ; 123(4): 279-286, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36416466

RESUMO

Spontaneous pneumothorax is a serious and life-threatening complication of SARS-CoV-2 pneumonia. It most commonly occurs during the acute phase of the disease in patients with pre-existing lung disease (e.g. emphysema, bronchiectasis, cystic fibrosis, etc.) and in patients who require oxygen supplementation in any form (low-flow oxygen therapy, high-flow non-invasive or mechanical invasive or mechanical invasion). A rare case of a 52-year-old patient with a spontaneous pneumothorax who developed four weeks after PCR SARS-CoV-2 positivity was described. Interestingly, the patient did not have any factors that the literature considered risky for the development of this complication. During the acute phase of the disease, his condition did not require hospitalization. Imaging examinations could not clarify the cause of pneumothorax. With this case report, we want to point out the fact that spontaneous pneumothorax, as a rare and life-threatening complication of COVID-19 infection, may develop during recovery, and it is necessary to think about this complication in the differential diagnosis of dyspnoea.


Assuntos
COVID-19 , Pneumotórax , Humanos , Pessoa de Meia-Idade , Pneumotórax/diagnóstico , Pneumotórax/etiologia , Pneumotórax/terapia , COVID-19/complicações , SARS-CoV-2
3.
Medicina (Kaunas) ; 58(6)2022 May 26.
Artigo em Inglês | MEDLINE | ID: mdl-35743977

RESUMO

Cerebrospinal fluid (CSF) leakage is a rare condition. Prompt diagnosis and early treatment of CSF leakage minimizes the risk of severe complications such as bacterial meningitis. Different diagnostic modalities are used to detect the site of CSF leakage but often with unreliable results. The literature offers limited evidence-based guidance on the diagnostic approach for rhinorrhea. Correct localization of the defect is the mainstay for successful surgical treatment. Herein, we describe a case of recurrent meningitis due to cranio-nasal fistula and rhinorrhea successfully localized with radioisotope cisternography (RIC). We provide a detailed and practical overview of the RIC procedure and compare different imaging modalities used to detect the site of CSF leakage.


Assuntos
Rinorreia de Líquido Cefalorraquidiano , Meningites Bacterianas , Rinorreia de Líquido Cefalorraquidiano/diagnóstico por imagem , Rinorreia de Líquido Cefalorraquidiano/cirurgia , Humanos , Meningites Bacterianas/diagnóstico por imagem , Ácido Pentético , Radioisótopos , Rinorreia
4.
Klin Mikrobiol Infekc Lek ; 28(1): 18-21, 2022 Mar.
Artigo em Eslovaco | MEDLINE | ID: mdl-36183413

RESUMO

The article describes the use of the last-resort carbapenem antibiotic imipenem in combination with relebactam, a novel b-lactamase inhibitor, in the treatment of ventilator-associated pneumonia developing after SARS-CoV-2 infection in a young pregnant patient. The introduction briefly describes the mechanism and spectrum of activity of the antibiotic, including its dosage.


Assuntos
COVID-19 , Pneumonia Associada à Ventilação Mecânica , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Compostos Azabicíclicos , Combinação Imipenem e Cilastatina , Humanos , Imipenem/farmacologia , Imipenem/uso terapêutico , Testes de Sensibilidade Microbiana , Pneumonia Associada à Ventilação Mecânica/tratamento farmacológico , SARS-CoV-2
5.
Psychiatr Danub ; 34(4): 752-757, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36548898

RESUMO

BACKGROUND: Previous research has shown that COVID-19 patients are at risk of developing mental disorders. Limited number of studies about psychiatric and neuropsychiatric presentations in hospitalized COVID-19 patients is currently available. SUBJECTS AND METHODS: Subjects were 172 patients diagnosed with COVID-19 and requiring inpatient care, hospitalized at reprofiled clinics of the university hospital. The study aimed to quantify psychiatric symptoms, and determine correlations with agitation, BMI, mortality, and other variables (age, sex, oxygen therapy, intubation, etc.). RESULTS: Mental disorders due to known physiological conditions were of highest prevalence (n=105, 62.9%), followed by anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders (n=34, 20.4%), and dementia (n=21, 12.6%) in COVID-19 patients. Depressive disorders (n=13, 7.9%), alcohol related disorders associated with withdrawal symptoms (n=10, 6%), and schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders (n=4, 2.4%) were less common. Patients diagnosed with mental disorders due to known physiological conditions were significantly older compared to patients with other diagnoses. The depression was observed more commonly in patients treated with high-flow nasal oxygen (HFNO), and patients disconnected from invasive mechanical ventilation (IMV). Mixed anxiety-depressive symptoms were observed in 23.8% of the patients (n=41), and they were more prevalent in younger patients compared to patients without anxiety-depressive symptoms. Agitated patients were significantly older than non-agitated patients. No connection was observed between the occurrence of agitation and treatment with HFNO, nor in case of patients disconnected from IMV; however, the relationship between agitation and death proved to be statistically significant (OR = 5.9, 95% CI 2.33-15.29). CONCLUSION: Analysis of psychiatric and neuropsychiatric presentations in COVID-19 patients and their correlation with multiple variables provides a better understanding of the effect of infection on mental health, and brings forth a necessity of transdisciplinary approach in handling COVID-19 patients.


Assuntos
COVID-19 , Transtornos Psicóticos , Humanos , COVID-19/epidemiologia , Transtornos de Ansiedade , Ansiedade , Oxigênio
6.
Cent Eur J Public Health ; 27(4): 330-334, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-31951694

RESUMO

OBJECTIVE: In recent years new infectious diseases, i.e. emerging or re-emerging diseases, have been coming to the forefront. Currently, microsporidia, considered to be a major cause of emerging and opportunistic infections particularly in immunocompromised individuals, are also included in this group. Therefore, the aim of our study was to map the prevalence of Encephalitozoon intestinalis and Enterocytozoon bieneusi infection in a group of patients and to compare it with the occurrence of specific antigens in immunocompetent people. METHODS: Detection of spores of both pathogens in faecal samples was performed by an immunofluorescence test using species-specific monoclonal antibodies. RESULTS: Positivity to E. intestinalis in 91 examined immunosuppressed patients reached 33% (30/91), while only 4.3% (3/70) of the control group samples were found to be positive (relative risk 7.7, p < 0.001). In case of E. bieneusi 14.3% (13/91) of immunocompromised patients were positive, as were 5.7% (4/70) of people from the control group (relative risk 2.5, p = 0.095). CONCLUSION: In case of development of any opportunistic infection, the infection is detected and removed in most cases at an early stage. The incidence of clinically manifested microsporidiosis in patients with immunodeficiency is rare as they are under constant medical supervision. However, we must not forget about opportunistic infections, and in case of any non-specific symptoms it is necessary to exclude or confirm the diagnosis for immediate treatment.


Assuntos
Encephalitozoon/isolamento & purificação , Encefalitozoonose/diagnóstico , Enterocytozoon/isolamento & purificação , Hospedeiro Imunocomprometido , Programas de Rastreamento , Microsporidiose/diagnóstico , Infecções Oportunistas/diagnóstico , Encefalitozoonose/epidemiologia , Fezes/microbiologia , Humanos , Microsporidiose/epidemiologia , Infecções Oportunistas/microbiologia , Eslováquia/epidemiologia
7.
Cent Eur J Public Health ; 26 Suppl: S76-S80, 2018 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-30817879

RESUMO

OBJECTIVE: Clostridium difficile infection (CDI) has become one of the most common causes of hospital-acquired infections. Fidaxomicin is one of the latest antibiotics used in the treatment of CDI, however, treatment cost affects recommendations for its use in several countries. We have analysed the treatment of our patients with CDI, treated by fidaxomicin since it was introduced to the market in 2018 and became available in the second biggest Slovak hospital, University Hospital of L. Pasteur. Our aim was to determine efficacy and safety of fidaxomicin in the treatment of CDI in Slovak patients. METHODS: We reviewed all courses of fidaxomicin use in our hospital (n = 60). Fidaxomicin was used for first recurrence (12 times), second recurrence (4 times), third recurrence (2 times), and fifth recurrence (1 patient). 41 patients received fidaxomicin first-line. RESULTS: Success of fidaxomicin treatment was recorded at 86.7% within the whole cohort. In the recurrent Clostridium difficile infection (rCDI) subgroup, fidaxomicin was 63% effective with three patients dying (15.7%) and two patients developing subsequent rCDI. During the duration of the study, 6 patients in total died. Only one of three patients, with three or more recurrences of CDI, had no further presentations after eight weeks of completion of treatment. CONCLUSIONS: The biggest benefit from fidaxomicin treatment was shown in a cohort of patients with primary CDI infection demonstrating a low recurrence rate and significant reduction of fidaxomicin effectiveness in preventing a recurrence when treating patients with multiple rCDI.


Assuntos
Antibacterianos/uso terapêutico , Clostridioides difficile/efeitos dos fármacos , Infecções por Clostridium/tratamento farmacológico , Fidaxomicina/uso terapêutico , Adolescente , Adulto , Idoso , Criança , Clostridioides difficile/isolamento & purificação , Infecções por Clostridium/diagnóstico , Humanos , Pessoa de Meia-Idade , Eslováquia/epidemiologia , Resultado do Tratamento , Adulto Jovem
8.
Neuro Endocrinol Lett ; 38(Suppl1): 9-26, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-29200249

RESUMO

OBJECTIVE: No previous analyses have attempted to determine optimal therapy for upper respiratory tract infections on the basis of cost-minimization models and the prevalence of antimicrobial resistance among respiratory pathogens in Slovakia. This investigation compares macrolides and cephalosporines for empirical therapy and look at this new tool from the aspect of potential antibiotic policy decision-making process. METHODS: We employed a decision tree model to determine the threshold level of macrolides and cephalosporines resistance among community respiratory pathogens that would make cephalosporines or macrolides cost-minimising. To obtain information on clinical outcomes and cost of URTIs, a systematic review of the literature was performed. The cost-minimization model of upper respiratory tract infections (URTIs) treatment was derived from the review of literature and published models. RESULTS: We found that the mean cost of empirical treatment with macrolides for an URTIs was €93.27 when the percentage of resistant Streptococcus pneumoniae in the community was 0%; at 5%, the mean cost was €96.45; at 10%, €99.63; at 20%, €105.99, and at 30%, €112.36. Our model demonstrated that when the percentage of macrolide resistant Streptococcus pneumoniae exceeds 13.8%, use of empirical cephalosporines rather than macrolides minimizes the treatment cost of URTIs. CONCLUSIONS: Empirical macrolide therapy is less expensive than cephalosporines therapy for URTIs unless macrolide resistance exceeds 13.8% in the community. Results have important antibiotic policy implications, since presented model can be use as an additional decision-making tool for new guidelines and reimbursement processes by local authorities in the era of continual increase in antibiotic resistance.


Assuntos
Antibacterianos/uso terapêutico , Tomada de Decisão Clínica , Farmacorresistência Bacteriana , Política de Saúde/economia , Sinusite/tratamento farmacológico , Doença Aguda , Antibacterianos/economia , Custos e Análise de Custo , Humanos , Sinusite/economia , Streptococcus pneumoniae
9.
Electrophoresis ; 36(23): 2925-30, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26264819

RESUMO

In our study, we examined 91 fecal samples from five different groups of people containing HIV patients, hemodialysis patients, kidney transplant recipients, immunocompetent humans without clinical signs, and humans with suspected cryptosporidiosis. The purpose of our study was to determine species and genotype composition of representatives of Cryptosporidium spp. using PCR analysis of small subunit ribosomal RNA gene and 60-kDa glycoprotein gene and examine their phylogenetic relationship. In HIV-positive/AIDS-infected group of patients and in hemodialysis patients, no presence of Cryptosporidium species was detected. In two kidney transplant recipients, we detected species/genotypes Cryptosporidium parvum IIaA13G1T1R1 (KT355488) and Cryptosporidium hominis IaA11G2R8 (KT355489) and in two immunocompetent patients with clinical symptoms, we identified Cryptosporidium muris and C. hominis IbA10G2T1 (KT355490). In the group of healthy immunocompetent individuals without clinical signs, we identified species/genotype C. hominis IbA11G2 (KT355491) in one sample.


Assuntos
Cryptosporidium/genética , Cryptosporidium/isolamento & purificação , Filogenia , Criptosporidiose/epidemiologia , Criptosporidiose/parasitologia , Cryptosporidium/patogenicidade , Cryptosporidium parvum/genética , Cryptosporidium parvum/isolamento & purificação , Cryptosporidium parvum/patogenicidade , Fezes/parasitologia , Infecções por HIV/parasitologia , Humanos , Hospedeiro Imunocomprometido , Reação em Cadeia da Polimerase , RNA Ribossômico/genética , Eslováquia/epidemiologia
10.
Cent Eur J Public Health ; 22 Suppl: S6-11, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24847607

RESUMO

BACKGROUND: Roma represent one of the largest and oldest minorities in Europe. Health of many of them, particularly those living in settlements, is heavily compromised by poor dwelling, low educational level, unemployment, and poverty rooted in generational poverty, segregation and discrimination. The cross-sectional population-based study using community based approach aimed to map the prevalence of viral hepatitis B/C and metabolic syndrome in the population living in separated and segregated Roma settlements and to compare it with the occurrence of the same health indicators in the majority population, considering selected risk and protective factors of these health indicators. METHODS: The sample consisted of 452 Roma (mean age = 34.7; 35.2% men) and 403 non-Roma (mean age = 33.5; 45.9% men) respondents. Data were collected in 2011 via questionnaire, anthropometric measures and analysed blood and urine samples. A methodology used in the study as well as in the following scientific papers is described in the Methods section (i.e. study design, procedures, samples, methods including questionnaire, anthropometric measurements, physical measurements, blood and urine measurements). CONCLUSIONS: There are regions of declining prosperity due to high unemployment, long-term problems with poverty and depleted resources. Populations living in these areas, i.e. in Central and Eastern Europe in Roma settlements, are at risk of poverty, social exclusion and other factors affecting health. Therefore, we should look for successful long-term strategies and tools (e.g. Roma mediators, terrain work) in order to improve the future prospects of these minorities.


Assuntos
Inquéritos Epidemiológicos/métodos , Hepatite B/etnologia , Hepatite C/etnologia , Síndrome Metabólica/etnologia , Características de Residência/estatística & dados numéricos , Roma (Grupo Étnico)/estatística & dados numéricos , Adolescente , Adulto , Estudos Transversais , Feminino , Nível de Saúde , Inquéritos Epidemiológicos/estatística & dados numéricos , Hepatite B/sangue , Hepatite B/urina , Hepatite C/sangue , Hepatite C/urina , Humanos , Masculino , Síndrome Metabólica/sangue , Síndrome Metabólica/urina , Pessoa de Meia-Idade , Pobreza/etnologia , Pobreza/estatística & dados numéricos , Prevalência , Roma (Grupo Étnico)/etnologia , População Rural/estatística & dados numéricos , Eslováquia/epidemiologia , Fatores Socioeconômicos , Inquéritos e Questionários , Adulto Jovem
11.
Cent Eur J Public Health ; 22 Suppl: S32-6, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24847612

RESUMO

BACKGROUND: We aimed to study the occurrence of Chlamydia trachomatis infection in the population living in Roma settlements and to compare the obtained results with the prevalence in the majority population. METHODS: We examined 340 people for the presence of bacterium C. trachomatis, 208 of them were Roma (66 men, 142 women) and 132 were from the majority population (75 men, 57 women). Respondents were aged 18-55 years (mean age = 33.44, STD = 9.57). The occurence of C. trachomatis was detected by direct proof of the pathogen by polymerase chain reaction (PCR). RESULTS: Of 340 respondents included in the study, 22 (6.5%) showed positivity for C. trachomatis infection, 15 of them were Roma (7.2%) and 7 non-Roma (5.3%). The highest positivity was detected in Roma women (8.5%), while positivity in both non-Roma women and men was 5.3%, and in Roma men 4.5%. We did not confirm any significant contribution of age, gender or ethnicity to the occurrence of C. trachomatis infection. CONCLUSIONS: Despite the increased number of people with risk factors in the Roma community, no significant difference in the occurrence of C. trachomatis infection was found. Neither age nor gender contributes to the probability of C. trachomatis infection. Nevertheless, there are other health consequences which might be more pronounced among the population living in Roma settlements due to barriers to the health care and their lower ability to benefit from health care services provided.


Assuntos
Infecções por Chlamydia/etnologia , Chlamydia trachomatis , Características de Residência/estatística & dados numéricos , Roma (Grupo Étnico)/estatística & dados numéricos , Adolescente , Adulto , Feminino , Inquéritos Epidemiológicos/métodos , Inquéritos Epidemiológicos/estatística & dados numéricos , Humanos , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase/métodos , Prevalência , Fatores de Risco , Roma (Grupo Étnico)/etnologia , População Rural/estatística & dados numéricos , Distribuição por Sexo , Eslováquia/epidemiologia , Adulto Jovem
12.
Cent Eur J Public Health ; 22 Suppl: S43-50, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24847614

RESUMO

BACKGROUND: Elevated gamma-glutamyl transpeptidase (GGT) is present approximately in half of all patients with non-alcoholic fatty liver disease (NAFLD). NAFLD is the liver manifestation of metabolic syndrome (MS). This study aimed to explore the relationship between GGT and MS or proinflammatory parameters. METHODS: Data from the cross-sectional HepaMeta study conducted in Slovakia in 2011 among Roma living in rural communities were used. Participants (n = 446) were divided into 2 groups; those with elevated GGT and those with normal GGT levels. MS was diagnosed according to the International Diabetes Federation criteria; presence of central obesity and low density lipoproteins (LDL) or high density lipoproteins (HDL), high triglycerides, hypertension, glucose intolerance or type 2 diabetes. Participants were tested for the presence of MS and its components, and biochemical tests for lipid levels (total cholesterol, HDL, LDL, TG) and inflammatory parameters (high sensitivity C-reactive protein--hs-CRP and ferritin) were performed. RESULTS: Of 446 Roma participants, only 29 (6.5%) had GGT levels above the normal value. After exclusion of patients with viral hepatitis and alcohol abuse, patients with elevated GGT suffered from MS more often (p < 0.001), and patients with more MS components had a higher risk of elevated GGT. We found a significant association between GGT and the individual MS components, except HDL (waist circumference > or = 94 cm in men or 80 cm in women: p < 0.01; BMI > 30: p < 0.001; fasting glucose > or = 5.6 mmol/l: p < 0.001; arterial hypertension: p < 0.05, and TAG > or = 1.7 mmol/l: p < 0.001). Patients with elevated GGT levels had also significantly higher hs-CRP (hs-CRP > 2 mg/l: p < 0.001; hs-CRP > 3 mg/l: p < 0.001) and ferritin (ferritin > 300 mg/l: p < 0.01) levels. CONCLUSION: Patients with MS have more significantly elevated levels of GGT. There is a significant association of GGT with individual MS components, except HDL and inflammatory parameters (hs-CRP, ferritin).


Assuntos
Inflamação/sangue , Inflamação/epidemiologia , Síndrome Metabólica/etnologia , Síndrome Metabólica/enzimologia , Roma (Grupo Étnico)/estatística & dados numéricos , gama-Glutamiltransferase/sangue , Adolescente , Adulto , Proteína C-Reativa , Comorbidade , Estudos Transversais , Dieta/etnologia , Dieta/métodos , Dieta/estatística & dados numéricos , Fígado Gorduroso/sangue , Fígado Gorduroso/etnologia , Feminino , Ferritinas/sangue , Inquéritos Epidemiológicos/métodos , Inquéritos Epidemiológicos/estatística & dados numéricos , Humanos , Inflamação/etnologia , Lipídeos/sangue , Masculino , Pessoa de Meia-Idade , Atividade Motora/fisiologia , Hepatopatia Gordurosa não Alcoólica , Fatores de Risco , Roma (Grupo Étnico)/etnologia , População Rural/estatística & dados numéricos , Eslováquia/epidemiologia , Fatores Socioeconômicos , Inquéritos e Questionários , Adulto Jovem
13.
Cent Eur J Public Health ; 22 Suppl: S69-74, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24847618

RESUMO

BACKGROUND: Obesity-induced metabolic syndrome is a multiple risk factor for cardiovascular (CV) risk factors and type 2 diabetes, and ethnic minorities seem to have unfavourable medical risk factors in general more frequently than majority populations. OBJECTIVE: The aim of this study was to evaluate the prevalence of cardiovascular risk factors in relation to metabolic syndrome in the Roma population compared with the non-Roma population residing in the eastern part of Slovakia. RESULTS: 123 Roma and 79 non-Roma patients with metabolic syndrome were evaluated. Men between 40-55 years of age had 4.76-times higher odds and women 5.26-times higher odds for metabolic sydrome compared with the younger population. We found statistically significant higher waist circumference in the Roma subpopulation and higher body mass index as well, although in selected population with metabolic syndrome. HDL cholesterol was significantly lower in both Roma men and women, and LDL cholesterol was not significant in men and women with metabolic syndrome. Triglycerides levels were significantly higher in non-Roma women only. High-sensitivity C-reactive protein (hsCRP) values were not in correlation with age but were associated with the increasing number of fulfilled criteria for metabolic syndrome in both subgroups (Roma, non-Roma), independently of gender. CONCLUSION: Our study confirmed higher prevalence of obesity, metabolic syndrome and other CV risk factors associated with metabolic syndrome among younger Roma population, which may be associated with increased cardiovascular disease (CVD) morbidity and mortality among elderly Roma compared with non-Roma.


Assuntos
Doenças Cardiovasculares/etnologia , Síndrome Metabólica/etnologia , Roma (Grupo Étnico)/estatística & dados numéricos , Adolescente , Adulto , Distribuição por Idade , Índice de Massa Corporal , Comorbidade , Dislipidemias/etnologia , Feminino , Humanos , Inflamação/etnologia , Masculino , Pessoa de Meia-Idade , Prevalência , Características de Residência/estatística & dados numéricos , Fatores de Risco , Roma (Grupo Étnico)/etnologia , População Rural/estatística & dados numéricos , Distribuição por Sexo , Eslováquia/epidemiologia , Adulto Jovem
14.
Cent Eur J Public Health ; 22 Suppl: S51-6, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24847615

RESUMO

BACKGROUND: Viral hepatitis B and C prevalence in the Roma population of eastern Slovakia is largely unknown. This study aimed to explore the prevalence and associated risk factors of chronic viral hepatitis B and C among Roma living in segregated communities in eastern Slovakia. METHODS: Data from the cross-sectional HepaMeta study conducted in Slovakia in 2011 among Roma living in rural communities were used. Participants were tested for the presence of HBsAg, anti-HBc IgG and anti-HCV. The risk factors were assessed mainly via a structured questionnaire/interview. RESULTS: Altogether 452 Roma were screened, and 11 were excluded due to missing data. A total of 441 patients were included (mean age 34.7 +/- 9.14 years; 35.2% men). 12.5% of participants were HBsAg positive, 40.4% anti-HBc IgG positive while negative for HBsAg and 47.2% of participants were negative for all serological markers of hepatitis B. Hepatitis C prevalence was very low (0.7%), while 2 out of 3 anti-HCV positive participants were coinfected with hepatitis B. Risk factors for hepatitis B infection were male sex, higher age, tattoo, and previous imprisonment. No difference was found in intravenous drug use, blood transfusions and sexual behaviour. CONCLUSION: More than half of the Roma residing in eastern Slovakia have been infected at one point in life with the hepatitis B virus, and 12.5% are HBsAg positive. Hepatitis C prevalence is very low, which is probably due to very low intravenous drug use.


Assuntos
Hepatite B/etnologia , Hepatite C/etnologia , Roma (Grupo Étnico)/estatística & dados numéricos , Adolescente , Adulto , Distribuição por Idade , Doença Crônica , Comorbidade , Estudos Transversais , Feminino , Inquéritos Epidemiológicos/métodos , Inquéritos Epidemiológicos/estatística & dados numéricos , Hepatite B/sangue , Hepatite C/sangue , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , Fatores de Risco , Roma (Grupo Étnico)/etnologia , População Rural/estatística & dados numéricos , Eslováquia/epidemiologia , Inquéritos e Questionários , Adulto Jovem
15.
Cent Eur J Public Health ; 22 Suppl: S75-80, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24847619

RESUMO

BACKGROUND: The metabolic syndrome (MS) is a clustering of cardiovascular risk. The high prevalence of metabolic syndrome among populations of lower socioeconomic status is a cause of concern and calls for an effective public health response. OBJECTIVES: The aim of this study was to determine the prevalence of metabolic syndrome in the Roma population compared with the non-Roma population in the eastern part of Slovakia and to determine the parameter which has the strongest association with metabolic syndrome. RESULTS: 123 Roma and 79 non-Roma patients with metabolic syndrome were evaluated. In the subgroup of Roma men, we found that waist circumference conferred the highest chance of MS (more than 12-times), followed by triglycerides (TG) (3.670-times). In the subgroup of non-Roma men, we found that waist circumference conferred the highest chance of MS (more than 16-times), followed by high-density lipoprotein (HDL) (4.348-times increased risk per one unit decrease in HDL). In the subgroup of Roma women as well as non-Roma women, we found that serum TG conferred the highest chance of MS, followed by waist circumference for Roma women. Comparing non-classical risk factors for MS we found that only age (with OR 1.977) and high-sensitivity C-reactive protein (hsCRP) (OR 1.887) were significant and independent predictors of MS in Roma men. Among Roma women apolipoprotein B100 was also found to be an independent predictor of MS, besides age and hsCRP. CONCLUSION: Our study confirmed that the prevalence of metabolic syndrome is strongly associated with hypertriglyceridemic waist, besides other risk factors, a marker of the atherogenic metabolic triad among younger Roma population, which may be the reason for the increased cardiovascular (CV) morbidity and mortality in elderly Roma compared with non-Roma. In light of these results, better prevention of CV events for Roma minority settlements in Slovakia should be provided.


Assuntos
Síndrome Metabólica/sangue , Síndrome Metabólica/etnologia , Roma (Grupo Étnico)/estatística & dados numéricos , Adolescente , Adulto , Distribuição por Idade , Apolipoproteína B-100/sangue , Biomarcadores/sangue , Índice de Massa Corporal , Proteína C-Reativa , Feminino , Humanos , Lipídeos/sangue , Lipoproteínas HDL/sangue , Masculino , Pessoa de Meia-Idade , Obesidade/sangue , Obesidade/etnologia , Razão de Chances , Prevalência , Características de Residência/estatística & dados numéricos , Fatores de Risco , Roma (Grupo Étnico)/etnologia , População Rural/estatística & dados numéricos , Distribuição por Sexo , Eslováquia/epidemiologia , Triglicerídeos/sangue , Circunferência da Cintura/etnologia , Circunferência da Cintura/fisiologia , Adulto Jovem
16.
Microorganisms ; 12(5)2024 May 20.
Artigo em Inglês | MEDLINE | ID: mdl-38792861

RESUMO

INTRODUCTION: The pandemic instigated by the SARS-CoV-2 virus has led to over 7 million deaths globally, primarily attributable to viral pneumonia. Identifying fundamental markers associated with an elevated risk of mortality can aid in the early identification of patients prone to disease progression to a severe state, enabling prompt intervention. METHODS: This was a single-center, retrospective study. RESULTS: In this study, we examined 299 patients admitted to the Department of Infectology and Travel Medicine in Kosice, Slovakia, with PCR-confirmed COVID-19 pneumonia. Patients were monitored from 1 January 2021 to 31 March 2021, with the endpoint being discharge from the hospital or death. All patient-related data were retrospectively collected from medical records. This study identified several risk factors significantly associated with an increased risk of mortality, including the requirement of HFNO (p < 0.001), age over 60 years (p < 0.001), Ne/Ly values of >6 (p < 0.001), as well as certain lymphocyte subtypes-CD4+ < 0.2 × 109/L (p = 0.035), CD8+ < 0.2 × 109/L (p < 0.001), and CD19+ < 0.1 × 109/L (p < 0.001)-alongside selected biochemical inflammatory markers-IL-6 > 50 ng/L (p < 0.001) and lactate > 3 mmol/L (p < 0.001). CONCLUSIONS: We confirmed that the mentioned risk factors were significantly associated with the death of patients from viral pneumonia in the hospital.

17.
Eur J Contracept Reprod Health Care ; 18(2): 95-103, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23286200

RESUMO

BACKGROUND AND OBJECTIVES: There is strong evidence that parental processes such as monitoring and social support play an important role with regard to sexual risk behaviour among adolescents. We wished to explore the influence of both parents' monitoring and support on sexual risk behaviour among adolescent boys and girls. METHODS: Questionnaires concerning sexual risk behaviour, parental support and parental monitoring were administered to 15-year-old students (n = 1343; 628 boys). Crude and adjusted logistic regression models were used to explore the effect of parents' monitoring and support on sexual risk behaviour among adolescent boys and girls. RESULTS: Parental monitoring was more strongly associated with sexual risk behaviour than parental social support. In particular, less monitoring by the father was significantly linked to early first sexual intercourse among girls and to not using a condom during last intercourse among boys. Less monitoring by the mother was associated only with not using a condom at last intercourse among boys. CONCLUSION: Parental monitoring, even more than parental support, may delay the onset of sexual activity and increase the frequency of condom use among adolescents. The effects of mothers' and fathers' parenting processes on sexual risk behaviour of adolescents differ. Paternal monitoring affects condom use among boys, and initiation of sexual activity in girls.


Assuntos
Comportamento do Adolescente/psicologia , Poder Familiar , Assunção de Riscos , Comportamento Sexual , Apoio Social , Adolescente , Feminino , Humanos , Modelos Logísticos , Masculino , Relações Pais-Filho , Estudantes/psicologia , Estudantes/estatística & dados numéricos , Inquéritos e Questionários
18.
Diagnostics (Basel) ; 13(5)2023 Mar 04.
Artigo em Inglês | MEDLINE | ID: mdl-36900127

RESUMO

Multisystem inflammatory syndrome in adults (MIS-A) is an uncommon but severe and still understudied post-infectious complication of COVID-19. Clinically, the disease manifests itself most often 2-6 weeks after overcoming the infection. Young and middle-aged patients are especially affected. The clinical picture of the disease is very diverse. The dominant symptoms are mainly fever and myalgia, usually accompanied by various, especially extrapulmonary, manifestations. Cardiac damage (often in the form of cardiogenic shock) and significantly increased inflammatory parameters are often associated with MIS-A, while respiratory symptoms, including hypoxia, are less frequent. Due to the seriousness of the disease and the possibility of rapid progression, the basis of a successful treatment of the patient is early diagnosis, based mainly on anamnesis (overcoming the disease of COVID-19 in the recent past) and clinical symptoms, which often imitate other severe conditions such as, e.g., sepsis, septic shock, or toxic shock syndrome. Because of the danger of missing the treatment, it is necessary to initiate it immediately after the suspicion of MIS-A is expressed, without waiting for the results of microbiological and serological examinations. The cornerstone of pharmacological therapy is the administration of corticosteroids and intravenous immunoglobulins, to which the majority of patients clinically react. In this article, the authors describe the case report of a 21-year-old patient admitted to the Clinic of Infectology and Travel Medicine for febrility up to 40.5 °C, myalgia, arthralgia, headache, vomiting, and diarrhea three weeks after overcoming COVID-19. However, as part of the routine differential diagnosis of fevers (imaging and laboratory examinations), their cause was not clarified. Due to the overall worsening of the condition, the patient was transferred to the ICU with suspicion of developing MIS-A (he met all clinical and laboratory criteria). Given the above, reserve antibiotics, intravenous corticosteroids, and immunoglobulins were added to the treatment due to the risk of missing them, with a good clinical and laboratory effect. After stabilizing the condition and adjusting the laboratory parameters, the patient was transferred to a standard bed and sent home.

19.
Pathogens ; 12(3)2023 Mar 08.
Artigo em Inglês | MEDLINE | ID: mdl-36986352

RESUMO

Dysbiosis of the gut microbiota, caused by antibiotics, plays a key role in the establishment of Clostridioides difficile CD). Toxin-producing strains are involved in the pathogenesis of Clostridioides difficile infection (CDI), one of the most common hospital-acquired infections. We cultured a total of 84 C. difficile isolates from stool samples of patients hospitalized at Louis Pasteur University Hospital in Kosice, Slovakia, that were suspected of CDI and further characterized by molecular methods. The presence of genes encoding toxin A, toxin B, and binary toxin was assessed by toxin-specific PCR. CD ribotypes were detected using capillary-based electrophoresis ribotyping. A total of 96.4% of CD isolates carried genes encoding toxins A and B, and 54.8% of them were positive for the binary toxin. PCR ribotyping showed the presence of three major ribotypes: RT 176 (n = 40, 47.6%); RT 001 (n = 23, 27.4%); and RT 014 (n = 7, 8.3%). Ribotype 176 predominated among clinical CD isolates in our hospital. The proportion of RT 176 and RT 001 in four hospital departments with the highest incidence of CDI cases was very specific, pointing to local CDI outbreaks. Based on our data, previous use of antibiotics represents a significant risk factor for the development of CDI in patients over 65 years of age.

20.
Artigo em Inglês | MEDLINE | ID: mdl-35627578

RESUMO

Inanimate surfaces are often referred to as nosocomial bacterial reservoirs and represent an important vector in the process of spreading pathogens to patients. Most gram-negative rods can survive on inanimate surfaces for several months. The aim of this study is to determine the prevalence and resistance of gram-negative bacteria isolated from the inanimate surfaces of two selected hospital departments. MALDI-TOF identified gram-negative rods isolated from inanimate surfaces. Antibiotic resistance was determined using a disk diffusion method, and the phenotype of resistance was determined using an inhibitory analyzer. From the inanimate surfaces, 98 strains of gram-negative nosocomial bacteria were identified by the MALDI-TOF MS. The most frequently isolated bacterium occurring in both departments was Pseudomonas aeruginosa (n = 33), followed by Acinetobacter baumannii (n = 20) and Enterobacter cloacae (n = 14). The most common phenotypic type of resistance in both departments was ampicillin resistance-AmpC (n = 38), then production of extended-spectrum ß-lactamase (ESBL) (n = 33), followed by SHV-1 (n = 11), TEM-1 (n = 11), and fluoroquinolone resistance-Qnr (n = 22). The nosocomial important enzymes capable of hydrolyzing carbapenems, OXA-48 and metallo-ß-lactamases, were confirmed in 12 and 2 cases, respectively. The results of our study prove that inanimate surfaces in hospitals are a reservoir of resistant gram-negative bacteria, which directly threaten hospitalized patients.


Assuntos
Infecção Hospitalar , Carbapenêmicos , Infecção Hospitalar/epidemiologia , Bactérias Gram-Negativas , Hospitais , Humanos , beta-Lactamases/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA